The number of people with susceptibility test result for rifampicin in Paraguay
Paraguay: The number of people with susceptibility test result for rifampicin was 92.7 in 2021. ▲ Rising
Latest (2021)
92.7
Change on year
up 64.2%
World rank
60th
of 146 countries
All-time high
92.7
in 2021
All-time low
26.88
in 2018
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Paraguay, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Paraguay is 92.7, measured in 2021. That is the highest value across all 5 years on record.
That represents a change of up 64.2% on the previous year and up 74.7% over five years.
Paraguay ranks 60th of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Paraguay, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 53.08 | — |
| 2018 | 26.88 | -49.3% |
| 2019 | 46.72 | +73.8% |
| 2020 | 56.47 | +20.9% |
| 2021 | 92.7 | +64.2% |
Paraguay compared with similar countries
- Paraguay's 92.7 is above the median for upper middle income countries, which is 92.7, 1.0× the median. (45 countries reporting)
- Paraguay's 92.7 is above the median for Latin America & Caribbean, which is 59.38, 1.6× the median. (21 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 42.23 | 26.88 | 53.08 | 3 |
| 2020s | 74.59 | 56.47 | 92.7 | 2 |
Countries ranked near Paraguay
More health data for Paraguay
- Un projection of annual infant deaths, annual growth rate -2.02 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.2374 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,098 deaths per 1,000 people (2090)
- Number of infants who die before age 1 339 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.5252 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0469 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5185 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Paraguay?
- The number of people with susceptibility test result for rifampicin in Paraguay was 92.7 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Paraguay?
- The highest recorded value was 92.7 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Paraguay?
- The lowest recorded value was 26.88 in 2018.
- How does Paraguay rank for the number of people with susceptibility test result for rifampicin?
- Paraguay ranks 60th out of 146 countries with data for 2021.
- Where does this Paraguay data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).